Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) EBT: 2021-2025

Historic EBT for Prime Medicine (PRME) over the last 4 years, with Sep 2025 value amounting to -$52.8 million.

  • Prime Medicine's EBT fell 0.60% to -$52.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$199.6 million, marking a year-over-year increase of 8.97%. This contributed to the annual value of -$195.9 million for FY2024, which is 1.28% up from last year.
  • As of Q3 2025, Prime Medicine's EBT stood at -$52.8 million, which was down 0.46% from -$52.6 million recorded in Q2 2025.
  • Over the past 5 years, Prime Medicine's EBT peaked at -$18.8 million during Q3 2021, and registered a low of -$65.6 million during Q4 2023.
  • In the last 3 years, Prime Medicine's EBT had a median value of -$51.9 million in 2025 and averaged -$50.1 million.
  • As far as peak fluctuations go, Prime Medicine's EBT soared by 35.85% in 2022, and later crashed by 74.40% in 2023.
  • Quarterly analysis of 5 years shows Prime Medicine's EBT stood at -$61.5 million in 2021, then soared by 35.85% to -$39.5 million in 2022, then plummeted by 66.32% to -$65.6 million in 2023, then surged by 35.60% to -$42.3 million in 2024, then declined by 0.60% to -$52.8 million in 2025.
  • Its EBT was -$52.8 million in Q3 2025, compared to -$52.6 million in Q2 2025 and -$51.9 million in Q1 2025.